| Literature DB >> 30196936 |
Abstract
Inquiry into declining pharmaceutical R&D efficiency has focussed on 'what' can be improved, with only brief thought given to 'who' can be improved. Here, we argue that enabling people in the idea-to-product chain to have a more holistic knowledge of the behaviours and incentives of each other can optimise R&D.Entities:
Keywords: R&D; academia; biotechnology; business and industry; pharmaceutical industry
Mesh：
Year: 2018 PMID： 30196936 DOI： 10.1016/j.tips.2018.08.002
Source DB: PubMed Journal: Trends Pharmacol Sci ISSN： 0165-6147 Impact factor: 14.819